Yoon YS - Search Results

1

Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behçet's disease.

Kwon Koo B, Shim WH, Yoon YS, Kwon Lee B, Choi D, Jang Y, Lee DY, Chang BC. Kwon Koo B, et al. Among authors: yoon ys. J Endovasc Ther. 2003 Feb;10(1):75-80. doi: 10.1177/152660280301000116. J Endovasc Ther. 2003. PMID: 12751935

2

Treatment of thoracic aortic dissection with stent-grafts: midterm results.

Shim WH, Koo BK, Yoon YS, Choi D, Jang Y, Lee DY, Chang BC. Shim WH, et al. Among authors: yoon ys. J Endovasc Ther. 2002 Dec;9(6):817-21. doi: 10.1177/152660280200900615. J Endovasc Ther. 2002. PMID: 12546583

3

Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair.

Kim SW, Jin HL, Kang SM, Kim S, Yoo KJ, Jang Y, Kim HO, Yoon YS. Kim SW, et al. Among authors: yoon ys. Int J Cardiol. 2016 Jan 15;203:498-507. doi: 10.1016/j.ijcard.2015.10.110. Epub 2015 Oct 23. Int J Cardiol. 2016. PMID: 26551883 Free PMC article.

4

Current State of Cardiovascular Research in Korea.

Shin JI, Oh J, Kim HC, Choi D, Yoon YS. Shin JI, et al. Among authors: yoon ys. Circ Res. 2019 Dec 6;125(12):1141-1145. doi: 10.1161/CIRCRESAHA.119.310859. Epub 2019 Dec 5. Circ Res. 2019. PMID: 31804914 Free PMC article.

5

Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Chen J, Zhang X, Millican R, Sherwood J, Martin S, Jo H, Yoon YS, Brott BC, Jun HW. Chen J, et al. Among authors: yoon ys. Adv Drug Deliv Rev. 2021 Mar;170:142-199. doi: 10.1016/j.addr.2021.01.005. Epub 2021 Jan 9. Adv Drug Deliv Rev. 2021. PMID: 33428994 Free PMC article. Review.

6

Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.

Ban K, Bae S, Yoon YS. Ban K, et al. Among authors: yoon ys. Theranostics. 2017 May 17;7(7):2067-2077. doi: 10.7150/thno.19427. eCollection 2017. Theranostics. 2017. PMID: 28638487 Free PMC article. Review.

7

Novel Multifunctional Nanomatrix Reduces Inflammation in Dynamic Conditions in Vitro and Dilates Arteries ex Vivo.

Alexander GC, Vines JB, Hwang P, Kim T, Kim JA, Brott BC, Yoon YS, Jun HW. Alexander GC, et al. Among authors: yoon ys. ACS Appl Mater Interfaces. 2016 Mar 2;8(8):5178-87. doi: 10.1021/acsami.6b00565. Epub 2016 Feb 17. ACS Appl Mater Interfaces. 2016. PMID: 26849167 Free PMC article.

8

Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.

Kim H, Kim JJ, Yoon YS. Kim H, et al. Among authors: yoon ys. Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):168-78. doi: 10.2174/187153012800493486. Endocr Metab Immune Disord Drug Targets. 2012. PMID: 22236028 Free PMC article. Review.

9

Direct reprogramming into endothelial cells: a new source for vascular regeneration.

Lee S, Kim JE, Johnson BA, Andukuri A, Yoon YS. Lee S, et al. Among authors: yoon ys. Regen Med. 2017 Apr;12(4):317-320. doi: 10.2217/rme-2017-0022. Epub 2017 Jun 16. Regen Med. 2017. PMID: 28621172 Free PMC article. Review. No abstract available.

10

Vascular Regeneration With New Sources of Endothelial Cells.

Lee S, Lee SJ, Yoon YS. Lee S, et al. Among authors: yoon ys. Circ Res. 2019 Jan 4;124(1):29-31. doi: 10.1161/CIRCRESAHA.118.314195. Circ Res. 2019. PMID: 30605418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,251 results

Search Page